{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:47:28Z","timestamp":1781732848323,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0904-9","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:03:16Z","timestamp":1566475396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Expression of eosinophil \u03b2 chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-343X","authenticated-orcid":false,"given":"Virginija","family":"Kalinauskaite-Zukauske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Januskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Janulaityte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skaidrius","family":"Miliauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestutis","family":"Malakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"12","key":"904_CR1","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/all.12275","volume":"68","author":"A Custovic","year":"2013","unstructured":"Custovic A, Johnston S, Pavord I, Gaga M, Fabbri L, Bel E, et al. EAACI position statement on asthma exacerbations and severe asthma. Allergy. 2013;68(12):1520\u201331.","journal-title":"Allergy."},{"issue":"2","key":"904_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jaip.2013.11.013","volume":"2","author":"WJ Calhoun","year":"2014","unstructured":"Calhoun WJ, Haselkorn T, Mink DR, Miller DP, Dorenbaum A, Zeiger RS. Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort. J Allergy Clin Immunol Pract. 2014;2(2):193\u2013200.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"13","key":"904_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198\u2013207.","journal-title":"N Engl J Med"},{"issue":"7","key":"904_CR4","first-page":"848","volume":"22","author":"B Chastek","year":"2016","unstructured":"Chastek B, Korrer S, Nagar SP, Albers F, Yancey S, Ortega H, et al. Economic burden of illness among patients with severe asthma in a managed care setting. J Manag Care Spec Pharm. 2016;22(7):848\u201361.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"904_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40413-016-0112-5","volume":"9","author":"TF Carr","year":"2016","unstructured":"Carr TF, Berdnikovs S, Simon H-U, Bochner BS, Rosenwasser LJ. Eosinophilic bioactivities in severe asthma. World Allergy Organ J. 2016;9(1):21.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"904_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaci.2011.04.047","volume":"128","author":"S Al-Muhsen","year":"2011","unstructured":"Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011;128(3):451\u201362.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"904_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells\u2014a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145.","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"904_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nri3349","volume":"13","author":"JA Walker","year":"2013","unstructured":"Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells\u2014how did we miss them? Nat Rev Immunol. 2013;13(2):75.","journal-title":"Nat Rev Immunol."},{"issue":"8","key":"904_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nm.3300","volume":"19","author":"GG Brusselle","year":"2013","unstructured":"Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med. 2013;19(8):977.","journal-title":"Nat Med"},{"issue":"2","key":"904_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4168\/aair.2010.2.2.87","volume":"2","author":"YM Park","year":"2010","unstructured":"Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res. 2010;2(2):87\u2013101.","journal-title":"Allergy Asthma Immunol Res"},{"key":"904_CR11","unstructured":"Koenderman L. Priming: a critical step in the control of eosinophil activation. In: Lee JJ, Rosenberg HF, editors. Eosinophils in Health and Disease. Amsterdam: Elsevier; 2013. p. 170\u20139. Available at: \n                    https:\/\/books.google.lt\/books?id=ADg8kX9lEdYC&pg=PA170&dq=Priming:+a+critical+step+in+the+control+of+eosinophil+activation&hl=lt&sa=X&ved=0ahUKEwjRt5WojtfjAhW0AxAIHReTDOYQ6AEIKDAA#v=onepage&q=Priming%3A%20a%20critical%20step%20in%20the%20control%20of%20eosinophil%20activation&f=false"},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2013.00033","volume":"4","author":"MW Johansson","year":"2013","unstructured":"Johansson MW, Mosher DF. Integrin activation states and eosinophil recruitment in asthma. Front Pharmacol. 2013;4:33.","journal-title":"Front Pharmacol"},{"issue":"2","key":"904_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.12382","volume":"279","author":"KF Chung","year":"2016","unstructured":"Chung KF. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med. 2016;279(2):192\u2013204.","journal-title":"J Intern Med"},{"issue":"1","key":"904_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-065X.2012.01164.x","volume":"250","author":"SE Broughton","year":"2012","unstructured":"Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, Bonder CS, et al. The GM\u2013CSF\/IL-3\/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol Rev. 2012;250(1):277\u2013302.","journal-title":"Immunol Rev"},{"issue":"1","key":"904_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0607344","volume":"83","author":"SR Barthel","year":"2008","unstructured":"Barthel SR, Johansson MW, McNamee DM, Mosher DF. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol. 2008;83(1):1\u201312.","journal-title":"J Leukoc Biol"},{"issue":"Pt3","key":"904_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1042\/bst0320434","volume":"32","author":"D Calderwood","year":"2004","unstructured":"Calderwood D. Talin controls integrin activation. Biochem Soc Trans. 2004 Jun;32(Pt3):434\u20137.","journal-title":"Biochem Soc Trans"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fphys.2016.00680","volume":"7","author":"A Januskevicius","year":"2017","unstructured":"Januskevicius A, Gosens R, Sakalauskas R, Vaitkiene S, Janulaityte I, Halayko AJ, et al. Suppression of eosinophil integrins prevents remodeling of airway smooth muscle in asthma. Front Physiol. 2017;7:680.","journal-title":"Front Physiol"},{"issue":"10118","key":"904_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","volume":"391","author":"ID Pavord","year":"2018","unstructured":"Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350\u2013400.","journal-title":"Lancet."},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12890-016-0254-9","volume":"16","author":"A Januskevicius","year":"2016","unstructured":"Januskevicius A, Vaitkiene S, Gosens R, Janulaityte I, Hoppenot D, Sakalauskas R, Malakauskas K. Eosinophils enhance WNT-5a and TGF-\u03b21 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma. BMC Pulm Med. 2016;16:94.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"904_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","volume":"11","author":"LE Katz","year":"2014","unstructured":"Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc. 2014;11(4):531\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"904_CR21","unstructured":"Mehta AA, Mahajan S. Role of cytokines in pathophysiology of asthma. IJPT. 2006;5(1):1\u20130. Available at: \n                    http:\/\/www.bioline.org.br\/pdf?pt06001."},{"issue":"4","key":"904_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cea.12292","volume":"44","author":"MW Johansson","year":"2014","unstructured":"Johansson MW. Activation states of blood eosinophils in asthma. Clin Exp Allergy. 2014;44(4):482\u201398.","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"904_CR23","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","volume":"170","author":"B Gregory","year":"2003","unstructured":"Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, Rankin SM, et al. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor \u03b1-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor \u03b1 expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor \u03b1 expression. J Immunol. 2003;170(11):5359\u201366.","journal-title":"J Immunol"},{"issue":"1","key":"904_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0006-291X(03)01526-2","volume":"309","author":"C Yoshimura-Uchiyama","year":"2003","unstructured":"Yoshimura-Uchiyama C, Yamaguchi M, Nagase H, Matsushima K, Igarashi T, Iwata T, et al. Changing expression of IL-3 and IL-5 receptors in cultured human eosinophils. Biochem Biophys Res Commun. 2003;309(1):26\u201331.","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"904_CR25","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1073\/pnas.89.15.7041","volume":"89","author":"J Tavernier","year":"1992","unstructured":"Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci U S A. 1992;89(15):7041\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"904_CR26","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.4049\/jimmunol.169.11.6459","volume":"169","author":"LY Liu","year":"2002","unstructured":"Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H, et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol. 2002;169(11):6459\u201366.","journal-title":"J Immunol"},{"issue":"5","key":"904_CR27","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaci.2011.05.032","volume":"128","author":"TM Wilson","year":"2011","unstructured":"Wilson TM, Maric I, Shukla J, Brown M, Santos C, Simakova O, et al. Interleukin-5 receptor \u03b1 levels in patients with marked eosinophilia or mastocytosis. J Allergy Clin Immunol. 2011;128(5):1086\u201392.","journal-title":"J Allergy Clin Immunol"},{"key":"904_CR28","doi-asserted-by":"crossref","unstructured":"Selvaraja M, Abdullah M, Shah AMd, Arip MB, Amin Nordin S. Role of cytokine il-5 and il-25 as biomarkers in systemic lupus erythematosus. Lupus Science & Medicine 2017;4.","DOI":"10.1136\/lupus-2017-000215.314"},{"key":"904_CR29","doi-asserted-by":"crossref","unstructured":"Wu Z, Zhong J, Su C, Huang Y, Huang T, Xu Z. Eosinophilia triggers changes in IL-5, eotaxin and IL-17, and acts as a prognostic biomarker for atopic dermatitis. Trop J Pharm Res. 2017;16(5):1167\u201372. Available at: \n                    https:\/\/www.ajol.info\/index.php\/tjpr\/article\/view\/157035\n                    \n                  .","DOI":"10.4314\/tjpr.v16i5.26"},{"issue":"1","key":"904_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13(1):9.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"904_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38(5):709\u201350.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"904_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1164\/rccm.200905-0745OC","volume":"182","author":"D Ramos-Barb\u00f3n","year":"2010","unstructured":"Ramos-Barb\u00f3n D, Fraga-Iriso R, Brienza NS, Montero-Mart\u00ednez C, Verea-Hernando H, Olivenstein R, et al. T cells localize with proliferating smooth muscle \u03b1-actin+ cell compartments in asthma. Am J Respir Crit Care Med. 2010;182(3):317\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4941","key":"904_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1967851","volume":"247","author":"CD Wegner","year":"1990","unstructured":"Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990;247(4941):456\u20139.","journal-title":"Science."},{"issue":"4","key":"904_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.exphem.2007.01.052","volume":"35","author":"ER Banerjee","year":"2007","unstructured":"Banerjee ER, Jiang Y, Henderson WR Jr, Scott LM, Papayannopoulou T. \u03b14 and \u03b22 integrins have nonredundant roles for asthma development, but for optimal allergen sensitization only \u03b14 is critical. Exp Hematol. 2007;35(4):605\u201317.","journal-title":"Exp Hematol"},{"issue":"4","key":"904_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1165\/rcmb.2012-0150OC","volume":"48","author":"MW Johansson","year":"2013","unstructured":"Johansson MW, Annis DS, Mosher DF. Alpha(M)beta (2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol. 2013;48(4):503\u201310.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"904_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12931-015-0218-2","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, Gao P, Zhi Y, Xu W, Wu Y, Yin J, et al. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res. 2015;16(1):57.","journal-title":"Respir Res"},{"issue":"11","key":"904_CR37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/1744666X.2014.962516","volume":"10","author":"HM Tartibi","year":"2014","unstructured":"Tartibi HM, Bahna SL. Clinical and biological markers of asthma control. Expert Rev Clin Immunol. 2014;10(11):1453\u201361.","journal-title":"Expert Rev Clin Immunol"},{"key":"904_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-pathol-012414-040343","volume":"10","author":"HE Trejo Bittar","year":"2015","unstructured":"Trejo Bittar HE, Yousem SA, Wenzel SE. Pathobiology of severe asthma. Annu Rev Pathol. 2015;10:511\u201345.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"904_CR39","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jaci.2011.12.979","volume":"129","author":"SJ Szefler","year":"2012","unstructured":"Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol. 2012;129(3):S9\u2013S23.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"904_CR40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF Jr, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"904_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/ACI.0000000000000028","volume":"14","author":"M-A Kim","year":"2014","unstructured":"Kim M-A, Shin YS, Pham LD, Park H-S. Adult asthma biomarkers. Curr Opin Allergy Clin Immunol. 2014;14(1):49\u201354.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9","key":"904_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/j.1365-2222.2005.02314.x","volume":"35","author":"M Berry","year":"2005","unstructured":"Berry M, Shaw D, Green R, Brightling C, Wardlaw A, Pavord I. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy. 2005;35(9):1175\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"904_CR43","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.jaci.2013.03.009","volume":"131","author":"N Scichilone","year":"2013","unstructured":"Scichilone N, Battaglia S, Taormina S, Modica V, Pozzecco E, Bellia V. Alveolar nitric oxide and asthma control in mild untreated asthma. J Allergy Clin Immunol. 2013;131(6):1513\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"904_CR44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973\u201384.","journal-title":"N Engl J Med"},{"issue":"10","key":"904_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/2012.jama.10893","volume":"308","author":"WJ Calhoun","year":"2012","unstructured":"Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. Jama. 2012;308(10):987\u201397.","journal-title":"Jama."},{"issue":"8","key":"904_CR46","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3109\/02770903.2014.917659","volume":"51","author":"D Wu","year":"2014","unstructured":"Wu D, Zhou J, Bi H, Li L, Gao W, Huang M, et al. CCL11 as a potential diagnostic marker for asthma? J Asthma. 2014;51(8):847\u201354.","journal-title":"J Asthma"},{"issue":"3","key":"904_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1399-3038.2011.01225.x","volume":"23","author":"E Machura","year":"2012","unstructured":"Machura E, Rusek-Zychma M, Jachimowicz M, Wrzask M, Mazur B, Kasperska-Zajac A. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria. Pediatr Allergy Immunol. 2012;23(3):278\u201384.","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"904_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","volume":"67","author":"CTH Nguyen","year":"2018","unstructured":"Nguyen CTH, Kambe N, Ueda-Hayakawa I, Kishimoto I, Ly NTM, Mizuno K, et al. TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis. Allergol Int. 2018 Oct;67(4):487\u201395.","journal-title":"Allergol Int"},{"key":"904_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/JAA.S15081","volume":"4","author":"S Wadsworth","year":"2011","unstructured":"Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy. 2011;4:77.","journal-title":"J Asthma Allergy"},{"issue":"26","key":"904_CR50","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"key":"904_CR51","doi-asserted-by":"crossref","unstructured":"Mathur SK, Schwantes EA, Jarjour NN, Busse WW. Age-related changes in eosinophil function in human subjects. Chest 2008; 133(2): 412\u2013419 .","DOI":"10.1378\/chest.07-2114"},{"issue":"24","key":"904_CR52","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier T, G\u00fcell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583(24):3966\u201373.","journal-title":"FEBS Lett"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0904-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0904-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0904-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:09:05Z","timestamp":1597964945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0904-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0904-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"8 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Regional Biomedical Research Ethics Committee of the Lithuanian University of Health Sciences (BE-2-13). Each participant provided informed written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consents have been obtained to publish from the participant to report individual patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}